Essex Financial Services Inc. Has $689,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Essex Financial Services Inc. lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,818 shares of the company’s stock after buying an additional 766 shares during the quarter. Essex Financial Services Inc.’s holdings in GE HealthCare Technologies were worth $689,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Cherry Creek Investment Advisors Inc. raised its stake in GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock worth $2,920,000 after buying an additional 114 shares during the period. Independence Bank of Kentucky increased its holdings in shares of GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after acquiring an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV raised its position in shares of GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after purchasing an additional 118 shares during the period. Custom Index Systems LLC lifted its holdings in shares of GE HealthCare Technologies by 4.4% in the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock worth $222,000 after purchasing an additional 120 shares in the last quarter. Finally, Greenleaf Trust grew its position in GE HealthCare Technologies by 1.7% in the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock valued at $715,000 after purchasing an additional 124 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.3 %

NASDAQ:GEHC opened at $85.90 on Thursday. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.55. The firm has a 50-day moving average price of $83.58 and a two-hundred day moving average price of $85.39. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a market cap of $39.25 billion, a price-to-earnings ratio of 23.60, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.85%.

Wall Street Analyst Weigh In

GEHC has been the topic of several research reports. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.77.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.